Antihyperalgesic effect of the cannabinoid agonist WIN55,212-2 is mediated through an interaction with spinal metabotropic glutamate-5 receptors in rats

This publication has 10 references indexed in Scilit:

• Chronic catheterization of the spinal subarachnoid space
  Published by Elsevier ,2003
• [3H]Methoxymethyl-3-[(2-methyl-1,3-thiazol-4-yl)ethynyl]pyridine Binding to Metabotropic Glutamate Receptor Subtype 5 in Rodent Brain: In Vitro and in Vivo Characterization
  The Journal of Pharmacology and Experimental Therapeutics, 2002
• Metabotropic glutamate receptor subtype 5 (mGlu5) and nociceptive function: I. Selective blockade of mGlu5 receptors in models of acute, persistent and chronic pain
  Neuropharmacology, 2001
• CB2 cannabinoid receptor-mediated peripheral antinociception
  Published by Wolters Kluwer Health ,2001
• The synthetic cannabinoid WIN55,212‐2 attenuates hyperalgesia and allodynia in a rat model of neuropathic pain
  British Journal of Pharmacology, 2001
• The role of central and peripheral Cannabinoid1 receptors in the antihyperalgesic activity of cannabinoids in a model of neuropathic pain
  Published by Wolters Kluwer Health ,2001
• Metabotropic and NMDA glutamate receptors participate in the cannabinoid-induced antinociception
  Neuropharmacology, 2001
• Cannabinoids modulate pain by multiple mechanisms of action
  The Journal of Pain, 2000
• The analgesic effects of R(+)-WIN 55,212–2 mesylate, a high affinity cannabinoid agonist, in a rat model of neuropathic pain
  Published by Elsevier ,1997
• A peripheral mononeuropathy in rat that produces disorders of pain sensation like those seen in man
  Pain, 1988